MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model

被引:5
作者
Sakamoto, Hiroki [1 ]
Miyanishi, Koji [1 ]
Tanaka, Shingo [1 ]
Ito, Ryo [1 ]
Hamaguchi, Kota [1 ]
Sakurada, Akira [1 ]
Sato, Masanori [1 ]
Kubo, Tomohiro [1 ]
Osuga, Takahiro [1 ]
Murase, Kazuyuki [1 ]
Takada, Kohichi [1 ]
Nakabeppu, Yusaku [3 ]
Kobune, Masayoshi [2 ]
Kato, Junji [1 ]
机构
[1] Sapporo Med Univ, Sch Med, Dept Med Oncol, Chuo Ku, South 1,West-16, Sapporo, Hokkaido 0608543, Japan
[2] Sapporo Med Univ, Sch Med, Dept Hematol, Chuo Ku, South 1,West-16, Sapporo, Hokkaido 0608543, Japan
[3] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Genom,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan
关键词
SERUM THIOREDOXIN LEVELS; FATTY LIVER-DISEASE; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; OXIDATIVE STRESS; MUTATIONS; RISK; MICE; PROGRESSION;
D O I
10.1038/s41598-021-83138-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Non-alcoholic steatohepatitis (NASH)-related HCC is associated with oxidative stress. However, the mechanisms underlying the development of NASH-related HCC is unclear. MUTYH is one of the enzymes that is involved in repair of oxidative DNA damage. The aim of this study was to investigate the association between MUTYH and NASH-related hepatocarcinogenesis. MUTYH wild-type (Mutyh(+/+)), heterozygous (Mutyh(+/-)), and MUTYH-null (Mutyh(-/-)) mice were fed a high-fat high-cholesterol (HFHC) diet or HFHC+high iron diet (20 mice per group) for 9 months. Five of 20 Mutyh(-/-) mice fed an HFHC+high iron diet developed liver tumors, and they developed more liver tumors than other groups (especially vs. Mutyh(+/+) fed an HFHC diet, P=0.0168). Immunohistochemical analysis revealed significantly higher accumulation of oxidative stress markers in mice fed an HFHC+high iron diet. The gene expression profiles in the non-tumorous hepatic tissues were compared between wild-type mice that developed no liver tumors and MUTYH-null mice that developed liver tumors. Gene Set Enrichment Analysis identified the involvement of the Wnt/beta -catenin signaling pathway and increased expression of c-Myc in MUTYH-null liver. These findings suggest that MUTYH deficiency is associated with hepatocarcinogenesis in patients with NASH with hepatic iron accumulation.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
    Kakehashi, Anna
    Suzuki, Shugo
    Wanibuchi, Hideki
    CANCERS, 2023, 15 (18)
  • [22] The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis
    Ando, Hitoshi
    Takamura, Toshinari
    Matsuzawa-Nagata, Naoto
    Shima, Kosuke R.
    Nakamura, Seiji
    Kumazaki, Masafumi
    Kurita, Seiichiro
    Misu, Hirofumi
    Togawa, Naoyuki
    Fukushima, Tatsunobu
    Fujimura, Akio
    Kaneko, Shuichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (03) : 684 - 688
  • [23] Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis
    Clarke, John D.
    Sharapova, Tatiana
    Lake, April D.
    Blomme, Eric
    Maher, Jonathan
    Cherrington, Nathan J.
    JOURNAL OF APPLIED TOXICOLOGY, 2014, 34 (06) : 726 - 732
  • [24] Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
    Hansen, Henrik H.
    Aegidius, Helene M.
    Oro, Denise
    Evers, Simon S.
    Heeboll, Sara
    Eriksen, Peter Lykke
    Thomsen, Karen Louise
    Bengtsson, Anja
    Veidal, Sanne S.
    Feigh, Michel
    Suppli, Malte P.
    Knop, Filip K.
    Gronbaek, Henning
    Miranda, Diego
    Trevaskis, James L.
    Vrang, Niels
    Jelsing, Jacob
    Rigbolt, Kristoffer T. G.
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [25] Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models
    Miyashita, Taishi
    Toyoda, Yasuyuki
    Tsuneyama, Koichi
    Fukami, Tatsuki
    Nakajima, Miki
    Yokoi, Tsuyoshi
    JOURNAL OF TOXICOLOGICAL SCIENCES, 2012, 37 (05) : 931 - 942
  • [26] Hyperlipidemic Chicken as a Model of Non-Alcoholic Steatohepatitis
    Ayala, Ignacio
    Martin Castillo, Antonia
    Adanez, Gracia
    Fernandez-Rufete, Ana
    Garcia Perez, Bartolome
    Castells, Maria T.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (01) : 10 - 16
  • [27] Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
    Gaemers, Ingrid C.
    Stallen, Jan M.
    Kunne, Cindy
    Wallner, Christian
    van Werven, Jochem
    Nederveen, Aart
    Lamers, Wouter H.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (04): : 447 - 458
  • [28] Emerging drugs for non-alcoholic steatohepatitis
    Tomeno, Wataru
    Yoneda, Masato
    Imajo, Kento
    Ogawa, Yuji
    Kessoku, Takaomi
    Saito, Satoru
    Eguchi, Yuichiro
    Nakajima, Atsushi
    EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (03) : 279 - 290
  • [29] Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis
    Terashima, Yoshihiko
    Nishiumi, Shin
    Minami, Akihiro
    Kawano, Yuki
    Hoshi, Namiko
    Azuma, Takeshi
    Yoshida, Masaru
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 555 : 55 - 65
  • [30] Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
    Morishita, Asahiro
    Tadokoro, Tomoko
    Fujihara, Shintaro
    Iwama, Hisakazu
    Oura, Kyoko
    Fujita, Koji
    Tani, Joji
    Takuma, Kei
    Nakahara, Mai
    Shi, Tingting
    Haba, Reiji
    Okano, Keiichi
    Nishiyama, Akira
    Ono, Masafumi
    Himoto, Takashi
    Masaki, Tsutomu
    PLOS ONE, 2022, 17 (02):